A New Headache For Bayer: A Patent Loss
culturekitchen | fresh dissent served daily wrote an interesting post today on
Here’s a quick excerpt
You know the old saying: Just when you think things can’t get worse…they do. The latest malady confronting the drugmaker is ruling by a federal judge that invalidated a patent on its Yasmin contraceptive pill, which gives Barr Laboratories a chance to sell a generic before the patent expires in 2020. For now, Bayer retains exclusive distribution rights in the US until March 2009, just one year from now. The news sent Bayer stock tumbling more than 5 percent, because Yasmin generated nearly $49
Get more information here